[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-364904-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-364904-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","multi-omic-analyses-reveal-ptpn6s-impact-on-tumor-immunity-across-various-cancers","Multi-omic analyses reveal PTPN6’s impact on tumor immunity across various cancers","","Protein Tyrosine Phosphatase Non-Receptor Type 6 (PTPN6) is a key regulatory molecule implicated in oncogenesis. A pan-cancer analysis was conducted to define PTPN6 involvement in multiple cancer types, focusing on tumor immunity. PTPN6 expression from open databases was integrated with survival, genetic heterogeneity, immune profiling, single-cell, drug sensitivity, and protein-interaction analyses, supported by colorectal cancer cell line experiments.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/multi-omic-analyses-reveal-ptpn6s-impact-on-tumor-immunity-across-various-cancers/364904/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/multi-omic-analyses-reveal-ptpn6s-impact-on-tumor-immunity-across-various-cancers/364904.png","ImageObject",300,407,{"name":42,"@type":43},"River Wang","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main goal of the pan-cancer analysis in this study?","Question",{"text":63,"@type":64},"To clarify how PTPN6 is involved across diverse cancer types, with a particular emphasis on its relationship to tumor immunity.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which analysis types were used to study PTPN6 in different cancers?",{"text":68,"@type":64},"Survival analysis, genetic heterogeneity analysis, immune profiling, single-cell analysis, drug sensitivity analysis, and protein interaction analysis were applied to PTPN6 expression data.",{"name":70,"@type":61,"acceptedAnswer":71},"What functional evidence supports PTPN6’s role in colorectal cancer?",{"text":72,"@type":64},"Knocking down PTPN6 reduced colorectal cancer cell proliferation and migration in vitro, supporting an oncogenic role in this cancer type.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},364904,1790636320,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nMulti-omic analyses reveal PTPN6’s impact on tumor immunity across various cancers  \nYuchen Zhong1,2,3,4, Weiyuan Zhang1,4, Chaojing Zheng1,2, HongyuWu2, Jun Luo1,2, Ziming Yuan1, Hao Zhang1, Chunlin Wang1, Haiyang Feng2, Meng Wang2, Qian Zhang2􀀍, Haixing Ju2􀀍 & Guiyu Wang1􀀍  \nProtein Tyrosine Phosphatase Non-Receptor Type 6 (PTPN6) plays a crucial regulatory role in cellular processes and has been implicated in oncogenesis. This pan-cancer analysis aimed to elucidate PTPN6’s involvement across various cancer types, with a particular emphasis on its association with tumor immunity. We analyzed PTPN6 expression data from open access databases using various statistical techniques, including survival analysis, genetic heterogeneity analysis, immune profiling, single  \ncell analysis, drug sensitivity analysis, and protein interaction analysis. We also conducted in vitro experiments utilizing colorectal cancer cell lines to validate PTPN6’s functional role. PTPN6 exhibited distinct expression patterns across cancers, and its prognostic significance was apparent in several cancer types, particularly in glioblastoma, sarcoma, and melanoma. We observed correlations between PTPN6 and immune genes/cell infiltration in these cancers, suggesting a potential role in modulating the tumor immune microenvironment. Single-cell analysis revealed that PTPN6 is predominantly localized in macrophages, B cells, and dendritic cells within the tumor microenvironment, implying its involvement in regulating immune cell function. Enrichment analysis highlighted PTPN6’s role in immune-related pathways. Drug sensitivity analysis identified specific drugs, including PAC-1, SNX- 2112, BELINOSTAT, VORINOSTAT, TPCA-1, and PHA-893,888, whose efficacy may be influenced by PTPN6 expression. Knocking down PTPN6 expression inhibited the proliferation and migration of colorectal cancer cells in vitro, confirming its oncogenic role in this cancer type. This pan-cancer analysis establishes PTPN6’s multifaceted influence on tumor immunity and its potential as abiomarker and therapeutic target.  \nAbbreviations  \nACCAELAML ALL BCC BLCABRCACESCCHOLCLL COAD  \nCOADREAD/COREAD  \nCRCDLBCESCA  \nAdrenocortical carcinoma Acute erythroidd leukemia  \nAcute myeloid leukemia Acute lymphoblastic leukemia Basal cell carcinoma Bladder urothelial carcinoma Breast invasive carcinoma  \nCervical squamous cell carcinoma and endocervical adenocarcinoma  \nCholangiocarcinoma Chronic lymphocytic leukemia Colon adenocarcinoma  \nColon adenocarcinoma/rectum adenocarcinoma esophageal carcinoma Colorectal cancer  \nLymphoid neoplasm diffuse large B-cell lymphoma Esophageal carcinoma  \n1Department of Colorectal Cancer Surgery, the Second Affiliated Hospital of Harbin Medical University, Harbin 150000, Heilongjiang, People’s Republic of China. 2Department of Colorectal Cancer Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, People’s Republic of China. 3Cancer Center, Department of Medical Oncology, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, People’s Republic of China. 4Yuchen Zhong and Weiyuan Zhang contributed equally to this work. 􀀍 [email: zhangqian1171@126.com](email: zhangqian1171@126.com); [juhx@zjcc.org.cn](juhx@zjcc.org.cn);  \n[guiywang@hrbmu.edu.cn](guiywang@hrbmu.edu.cn)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nGCTB  \nGBMGBMLGGGIST  \nHNSC  \nKICH KIPANKIRC  \nKIRP  \nLAML  \nLGG  \nLIHC  \nLUAD  \nLUSC  \nLSCC  \nMB  \nMCC  \nMESO  \nMF  \nMMMPNST NB  \nNHL  \nNPC  \nOV  \nOS  \nOSCC  \nPAAD  \nPBMC PCFCL PCPG  \nPRAD  \nREAD  \nSARC  \nSTAD  \nSKCM  \nSCC  \nSCLC  \nSTES  \nSS  \nTGCT  \nTHCA  \nTHYM  \nUCEC  \nUCS  \nUVM  \nWT  \nGiant cell tumor of bone Glioblastoma multiforme Glioma  \nGastrointestinal stromal tumor  \nHead and neck squamous cell carcinoma Kidney chrom","cbCaiqH9QxVEajQZ","https://ap.wps.com/l/cbCaiqH9QxVEajQZ","pdf",4948782,21,"English","# Background\n# Methods\n## Multi-omic and immune profiling\n## In vitro validation\n# Key Findings\n## Expression and prognostic value\n## Links with immune genes and infiltration\n## Single-cell localization\n## Pathway enrichment\n## Drug sensitivity associations\n# Functional validation\n# Implications","[{\"question\":\"What was the main goal of the pan-cancer analysis in this study?\",\"answer\":\"To clarify how PTPN6 is involved across diverse cancer types, with a particular emphasis on its relationship to tumor immunity.\"},{\"question\":\"Which analysis types were used to study PTPN6 in different cancers?\",\"answer\":\"Survival analysis, genetic heterogeneity analysis, immune profiling, single-cell analysis, drug sensitivity analysis, and protein interaction analysis were applied to PTPN6 expression data.\"},{\"question\":\"What functional evidence supports PTPN6’s role in colorectal cancer?\",\"answer\":\"Knocking down PTPN6 reduced colorectal cancer cell proliferation and migration in vitro, supporting an oncogenic role in this cancer type.\"}]","Multi-omic analyses reveal PTPN6’s impact on tumor immunity across various cancers | PDF",1790159374,53,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a4ca27d1999c93acb1f861e1f3a84ccb.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7a7b0647b3dbfe001aceba20621aa0bd.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cc230ec908e862680391d83c9c42062a.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/73c3cc5cc04d4559a5f22491021c9398.webp",980,1287]